Full Press Release Details
Immutep Appoints Dr. Florian Vogl as Chief Medical Officer.
IMMP
Immutep Appoints Dr. Florian Vogl as Chief Medical Officer
Key Takeaway: Immutep Appoints Dr. Florian Vogl as Chief Medical Officer
Price reaction · baseline $1.66 (2023-04-25 close) · hit after-hours · 2 other IMMP headline(s) in the window, move may be shared
day 0 close
-1.2%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+76%
120-day peak, hindsight
Typical move
5.4%
average across 13 past catalysts
Lead asset
eftilagimod alfa
Phase 3 · Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)